Case Studies: Real Results from Probiotic Environmental Treatment
These case studies document measurable outcomes from EnviroBiotics deployments, conducted by independent research organizations and universities. Each study follows rigorous scientific protocols with control groups and validated measurements.
Caring for Our Pets: Reducing Atopic Dermatitis in Dogs
Dogs with atopic skin conditions have fewer species of bacteria on their skin compared to healthy dogs, contributing to a compromised skin barrier, increased itch, and skin odor. A pilot study designed, executed, and analyzed by Invetus (Yorklea, Australia) and managed by Orivet Genetic Pet Care evaluated the effects of regular topical application of EnviroBiotics on dogs with atopic dermatitis and their sleeping area over 21 days.
The EnviroBiotics treatment reduced pruritus incidence by 0.6% per day, which was statistically significant (p=0.022). Odor assessment decreased by 0.57% daily. Owners reported a clear reduction of skin and bedding odor, demonstrating relief for both pets and their owners.
Source: Invetus – Yorklea, Australia. A copy of the 79 pages of research is available upon request.
Suppressing COVID-19 on Surfaces: 97.7% Viral Neutralization
In experiments carried out at Genova University's Department of Experimental Medicine, EnviroBiotics liquids were incubated with SARS-CoV-2 viral particles. Scientists observed and measured the breaking down of the Spike protein: the vehicle for viral attachment to human cells, membrane fusion, and subsequent infection.
Results showed 67% of viruses neutralized within 15 minutes, with continued exposure for 3 hours increasing neutralization to 97.7%. Control surfaces showed no spontaneous viral reduction, confirming all reduction was attributed to EnviroBiotics activity. A colony-forming assay validated the virucidal efficiency.
Source: Department of Experimental Medicine, University of Genova, Italy.
Asthma and Allergies Prevention: Eliminating Allergens at the Source
Modern indoor living fosters the proliferation of allergens such as mold toxins, dust mite protein waste, pet dander, and pollen. EnviroBiotics includes probiotic strains whose Bacillus cells secrete proteolytic enzymes that degrade allergenic proteins, neutralizing them at the source rather than merely treating symptoms.
Studies conducted by Indoor Biotechnologies (Cardiff, UK) and EMSL Analytical Laboratories (New Jersey, USA) confirmed that EnviroBiotics dramatically decreases allergen concentrations, with a cumulative effect over time. Dr. Sivasankar Baalasubramanian, Executive Director of Indoor Biotechnologies, concluded: "EnviroBiotics can grow and prosper by using allergens as a nutrient source, hence dramatically decreasing the concentration of allergens and reducing the pathogenic effects of ubiquitous indoor allergens on human residents."
Sources: Indoor Biotechnologies (UK/USA/India) and EMSL Analytical Laboratories (New Jersey, USA). Read the full research.
Supporting Scientific Publications
Independent peer-reviewed research supports the EnviroBiotics approach. Studies published in leading journals demonstrate the risks of chemical disinfectants and the efficacy of probiotic alternatives:
- Chlorine disinfectants' impact: Widely used chemical disinfectants provide short-term efficacy at significant cost to people and environment. Published in Environmental Science and Pollution Research.
- Detergent exposure and lung function: A study of 6,350 adults shows increased exposure to cleaning materials is linked to a decline in lung function. Published in American Journal of Respiratory and Critical Care Medicine.
- Probiotic cleaning in hospitals: Multi-year deployment of probiotic cleaners in hospitals showed steep decline in nosocomial infections and higher overall hygiene. Published in PLOS ONE.
Get the same results in your home
Choose an EnviroBiotics device to start reducing allergens, odors, and pathogens on your surfaces.


